Evaluation of 71 Coronary Artery Disease Risk Variants in a Multiethnic Cohort

Wangjing Ke1, Kristin A Rand2, David V Conti1

  • 1Department of Preventive Medicine, Keck School of Medicine of USC, Los Angeles, CA, United States.

Insights

Most known coronary heart disease (CHD) genetic risk factors show similar effects across diverse populations. However, larger studies are needed to confirm these findings and identify specific functional variants in underrepresented groups.

Area of Science:

  • Genetics
  • Cardiovascular Disease Epidemiology
  • Population Genetics

Background:

  • Coronary heart disease (CHD) is a leading global cause of mortality.
  • Previous genetic studies primarily focused on European ancestry populations.
  • The generalizability of identified CHD susceptibility loci to other ethnic groups is largely unknown.

Purpose of the Study:

  • To evaluate the transferability of 71 established coronary heart disease (CHD) genetic loci across diverse populations.
  • To assess the predictive power of aggregated single nucleotide polymorphism (SNP) risk for CHD in African Americans, Latinos, and Japanese individuals.

Main Methods:

  • Examined associations of 71 known CHD loci in 6,035 cases and 11,251 controls from the Multiethnic Cohort.
  • Assessed directional consistency of odds ratios for identified loci across ethnic groups.
  • Constructed and evaluated genetic risk scores (GRSs) for CHD prediction in different populations.

Main Results:

  • 78% of studied CHD loci showed directionally consistent associations in a combined multiethnic sample.
  • Significant associations varied by ethnicity, with 11 loci in African Americans and only 1 in Japanese individuals.
  • Genetic risk scores significantly predicted CHD in African Americans and Latinos, but not in Japanese individuals.

Conclusions:

  • A substantial proportion of known coronary heart disease (CHD) genetic loci generalize across diverse populations.
  • Further fine-mapping studies are essential to pinpoint causal variants and elucidate their role in CHD risk across ethnicities.
  • Genetic risk scores demonstrate predictive utility in African Americans and Latinos, highlighting population-specific genetic contributions to CHD.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
516
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
298
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
411
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
733
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
452